Drug & medication recalls Moderate risk

Lactulose Solution recalled over manufacturing violations

Recall date
April 26, 2023
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Akorn, Inc. recalls Lactulose Solution, USP (Oral), 10g/15 mL, packaged in a) 15mL bottles, b) 30 mL bottles, c) 473 mL bottles, and d) 946…
Recall number
D-0814-2023
FDA classification
Class II
Brand / firm
Akorn, Inc.
Sold / distributed
Nationwide in the USA and Puerto Rico

Why it was recalled

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Lactulose Solution, USP (Oral), 10g/15 mL, packaged in a) 15mL bottles, b) 30 mL bottles, c) 473 mL bottles, and d) 946 mL bottles, Rx Only, Distributed by: Akorn, Inc., Gurnee, IL 60031. ALL NDCs

Get recall alerts

Free email alert whenever Akorn, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Akorn, Inc.